R&D Sponsored The importance of time: Grifols seeks biomarkers for early d... Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.
News Grifols gets $21m award for Parkinson's biomarker hunt Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start.
News Grifols files drug for rare bleeding disorder in the US Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.
News Grifols slides as Brookfield pulls out of takeover talks Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's shares
News Grifols linked to €7bn takeover offer from Brookfield Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.
News Could Spain’s Grifols be heading for de-listing? The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almo
News NHS records to be harnessed in pancreatic cancer screening The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
